Vaping and e-cigarette use. Mysterious lung manifestations and an epidemic
-
Published Date:
November 10 2020
Source:Curr Opin Immunol. 66:143-150Language:English -
Alternative Title:Curr Opin Immunol
-
Personal Author:
-
Description:Electronic (e)-cigarette use and the practice of vaping has rapidly expanded both in adult smokers and previously nicotine naïve youths. Research has focused on harm reduction in adults using e-cigarettes to stop or reduce traditional cigarette use, but the short and long-term safety of these products has not been established. Vaping has more recently been associated with a growing list of pulmonary complications with the most urgent being the e-cigarette or vaping product use-associated lung injury (EVALI) epidemic. This review details the inhalant toxicology of vaping products, the described lung diseases associated with vaping with a focus on EVALI, and the predicted long-term consequences of e-cigarette use, including increased asthma severity.
-
Subject:
-
Pubmed ID:33186869
-
Pubmed Central ID:PMC7755270
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
-
Supporting Files:No Additional Files
Public Access Version Available on:
November 10, 2021, 12:00 AM
Details:
No Related Documents.
You May Also Like:
-
[PDF - 410.83 KB]
Published Date:Source:Description:Public Access Available on:File Type:[PDF - 410.83 KB]
[PDF - 1.97 MB]
Published Date:Source:Description:File Type:[PDF - 1.97 MB]
File Type:[PDF - 1.97 MB]
[PDF - 28.51 KB]
Published Date:Source:File Type:[PDF - 28.51 KB]
File Type:[PDF - 28.51 KB]
[PDF - 538.05 KB]
Published Date:Description:File Type:[PDF - 538.05 KB]
File Type:[PDF - 538.05 KB]
[PDF - 110.85 KB]
Published Date:Description:File Type:[PDF - 110.85 KB]
File Type:[PDF - 110.85 KB]
Have Questions?
Visit CDC Info
Email
CDC-INFO
Open 24/7
CDC INFORMATION
CONNECT WITH CDC
